Literature DB >> 21737445

Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.

Mee-Sup Yoon1, Yuting Sun, Edwin Arauz, Yu Jiang, Jie Chen.   

Abstract

Phosphatidic acid (PA) is a critical mediator of mitogenic activation of mammalian target of rapamycin complex 1 (mTORC1) signaling, a master regulator of mammalian cell growth and proliferation. The mechanism by which PA activates mTORC1 signaling has remained unknown. Here, we report that PA selectively stimulates mTORC1 but not mTORC2 kinase activity in cells and in vitro. Furthermore, we show that PA competes with the mTORC1 inhibitor, FK506 binding protein 38 (FKBP38), for mTOR binding at a site encompassing the rapamycin-FKBP12 binding domain. This leads to PA antagonizing FKBP38 inhibition of mTORC1 kinase activity in vitro and rescuing mTORC1 signaling from FKBP38 in cells. Phospholipase D 1, a PA-generating enzyme that is an established upstream regulator of mTORC1, is found to negatively affect mTOR-FKBP38 interaction, confirming the role of endogenous PA in this regulation. Interestingly, removal of FKBP38 alone is insufficient to activate mTORC1 kinase and signaling, which require PA even when the FKBP38 level is drastically reduced by RNAi. In conclusion, we propose a dual mechanism for PA activation of mTORC1: PA displaces FKBP38 from mTOR and allosterically stimulates the catalytic activity of mTORC1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737445      PMCID: PMC3190997          DOI: 10.1074/jbc.M111.262816

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  The expanding TOR signaling network.

Authors:  Dietmar E Martin; Michael N Hall
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

Review 2.  Phosphatidic acid- and phosphatidylserine-binding proteins.

Authors:  Catherine L Stace; Nicholas T Ktistakis
Journal:  Biochim Biophys Acta       Date:  2006-04-03

Review 3.  Regulation of mTOR by phosphatidic acid?

Authors:  David A Foster
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

4.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

Authors:  Yasemin Sancak; Carson C Thoreen; Timothy R Peterson; Robert A Lindquist; Seong A Kang; Eric Spooner; Steven A Carr; David M Sabatini
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

5.  Rheb binds and regulates the mTOR kinase.

Authors:  Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Kazuyoshi Yonezawa; Joseph Avruch
Journal:  Curr Biol       Date:  2005-04-26       Impact factor: 10.834

6.  Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

Authors:  Xiaochun Bai; Dongzhu Ma; Anling Liu; Xiaoyun Shen; Qiming J Wang; Yongjian Liu; Yu Jiang
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

7.  Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.

Authors:  Emmanuelle Billon-Denis; Zahra Tanfin; Philippe Robin
Journal:  J Lipid Res       Date:  2007-11-16       Impact factor: 5.922

Review 8.  Defining the role of mTOR in cancer.

Authors:  David A Guertin; David M Sabatini
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

9.  PLD regulates myoblast differentiation through the mTOR-IGF2 pathway.

Authors:  Mee-Sup Yoon; Jie Chen
Journal:  J Cell Sci       Date:  2008-01-15       Impact factor: 5.285

10.  Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.

Authors:  V Veverka; T Crabbe; I Bird; G Lennie; F W Muskett; R J Taylor; M D Carr
Journal:  Oncogene       Date:  2007-08-06       Impact factor: 9.867

View more
  61 in total

1.  Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice.

Authors:  George G Schweitzer; Zhouji Chen; Connie Gan; Kyle S McCommis; Nisreen Soufi; Roman Chrast; Mayurranjan S Mitra; Kui Yang; Richard W Gross; Brian N Finck
Journal:  J Lipid Res       Date:  2015-02-26       Impact factor: 5.922

2.  A Unique Homeostatic Signaling Pathway Links Synaptic Inactivity to Postsynaptic mTORC1.

Authors:  Fredrick E Henry; Xiao Wang; David Serrano; Amanda S Perez; Cynthia J L Carruthers; Edward L Stuenkel; Michael A Sutton
Journal:  J Neurosci       Date:  2018-01-08       Impact factor: 6.167

3.  Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid.

Authors:  Mee-Sup Yoon; Christina L Rosenberger; Cong Wu; Nga Truong; Jonathan V Sweedler; Jie Chen
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

Review 4.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

5.  Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.

Authors:  Mohamad El Osta; Mengling Liu; Mohamad Adada; Can E Senkal; Jolanta Idkowiak-Baldys; Lina M Obeid; Christopher J Clarke; Yusuf A Hannun
Journal:  FASEB J       Date:  2013-10-11       Impact factor: 5.191

6.  Reciprocal regulation of AMP-activated protein kinase and phospholipase D.

Authors:  Suman Mukhopadhyay; Mahesh Saqcena; Amrita Chatterjee; Avalon Garcia; Maria A Frias; David A Foster
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

7.  Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics.

Authors:  Suzanne M de la Monte; Jared Kay; Emine B Yalcin; Jillian J Kril; Donna Sheedy; Greg T Sutherland
Journal:  Alcohol       Date:  2017-08-17       Impact factor: 2.405

8.  FKBP38 peptidylprolyl isomerase promotes the folding of cystic fibrosis transmembrane conductance regulator in the endoplasmic reticulum.

Authors:  Yeshavanth K Banasavadi-Siddegowda; Junbo Mai; Yifei Fan; Sumit Bhattacharya; David R Giovannucci; Edwin R Sanchez; Gunter Fischer; Xiaodong Wang
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

9.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Hepatic gluconeogenesis is enhanced by phosphatidic acid which remains uninhibited by insulin in lipodystrophic Agpat2-/- mice.

Authors:  Shireesha Sankella; Abhimanyu Garg; Jay D Horton; Anil K Agarwal
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.